SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unichem Laboratories board to consider interim dividend

06 Jan 2014 Evaluate

Unichem Laboratories has informed that a meeting of the Board of Directors of the Company will be held on January 18, 2014, to consider and take on record Un-audited Accounts for the quarter ended December 31, 2013 and to consider interim dividend, if any for the financial year 2013-14.

The above information is a part of company’s filings submitted to BSE.

Unichem Lab Share Price

451.00 2.95 (0.66%)
23-Jun-2026 10:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1896.85
Dr. Reddys Lab 1314.15
Cipla 1450.00
Zydus Lifesciences 1106.15
Lupin 2374.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: